InvestorsHub Logo
Post# of 24568
Next 10
Followers 1
Posts 420
Boards Moderated 0
Alias Born 01/17/2006

Re: None

Wednesday, 06/02/2010 9:33:21 AM

Wednesday, June 02, 2010 9:33:21 AM

Post# of 24568
bot IMUC - ImmunoCellular Therapeutics’ ICT-107 Demonstrates 80 Percent Survival at 2 Years in Phase I Study of Newly Diagnosed Glioblastoma Patients
8:00 AM ET - Business Wire
Data to Be Presented at Annual Meeting of American Society of Clinical Oncology.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.